New painkiller candidate FZ008-145 passes first safety check in healthy volunteers
NCT ID NCT06685809
First seen Feb 22, 2026 · Last updated May 29, 2026 · Updated 13 times
Summary
This early-stage study tested a new drug called FZ008-145 in 176 healthy adults to see if it is safe and how the body processes it. Researchers also measured pain tolerance using a cold water test. The goal was to gather basic safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMAX Clinical Research Pty
Adelaide, South Australia, 5000, Australia
Conditions
Explore the condition pages connected to this study.